Basket | Login


PharmaCog researchers show results at EACPT conference

Sunday 28 June 2015

PharmaCog researchers Claudio Babiloni, David Bartrés-Faz, Régis Bordet and Pablo Martinez Lage (pictured L-R) all attended the 12th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), which was held in Barcelona on 27-30 June.

Alzheimer’s disease was the focus of a key session of the conference, including presentations by Dr Bordet (Disease modifiers in Alzheimer's disease: towards a multimodal strategy) and Dr Bartrés-Faz (How cognitive challenge models can improve the sensitivity of the biomarker battery to test symptomatic treatments: the PharmaCog project approach).

The four colleagues also featured in an interview where they discussed the development of new treatments and why previous treatment approaches may not have worked. They also presented PharmaCog’s approach to develop new biomarkers in order to speed up successful drug development. The 20+ minute interview is available on YouTube.